Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous fibrinogen for acute gastrointestinal bleeding
IRCT20140528017891N6Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of Fibrinogen human in gastrointestinal bleeding, sponsored by Iran University of Medical Sciences. Primary endpoint: Rebleeding. Started Jan 2019; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
gastrointestinal bleeding
Beyond the preview
Go deeper on IRCT20140528017891N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140528017891N6.